These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 38411110

  • 1. Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms.
    Kunz Coyne AJ, Stamper K, Bleick C, Kebriaei R, Lehman SM, Rybak MJ.
    Microbiol Spectr; 2024 Apr 02; 12(4):e0321223. PubMed ID: 38411110
    [Abstract] [Full Text] [Related]

  • 2. Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model.
    Kunz Coyne AJ, Bleick C, Stamper K, Kebriaei R, Bayer AS, Lehman SM, Rybak MJ.
    Antimicrob Agents Chemother; 2024 Apr 03; 68(4):e0138823. PubMed ID: 38376187
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE, Smith JR, Ireland CE, Boles BR, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2015 Aug 03; 59(8):4497-503. PubMed ID: 25987623
    [Abstract] [Full Text] [Related]

  • 4. Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model.
    Kunz Coyne AJ, Stamper K, El Ghali A, Kebriaei R, Biswas B, Wilson M, Deschenes MV, Tran TT, Arias CA, Rybak MJ.
    Microbiol Spectr; 2023 Aug 17; 11(4):e0034023. PubMed ID: 37338375
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus.
    Tsai CE, Yang CJ, Chuang YC, Wang JT, Sheng WH, Chen YC, Chang SC.
    Int J Infect Dis; 2022 Sep 17; 122():230-236. PubMed ID: 35640827
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of ceftaroline activity versus daptomycin (DAP) against DAP-nonsusceptible methicillin-resistant Staphylococcus aureus strains in an in vitro pharmacokinetic/pharmacodynamic model.
    Steed M, Vidaillac C, Rybak MJ.
    Antimicrob Agents Chemother; 2011 Jul 17; 55(7):3522-6. PubMed ID: 21576449
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Werth BJ, Barber KE, Ireland CE, Rybak MJ.
    Antimicrob Agents Chemother; 2014 Jun 17; 58(6):3177-81. PubMed ID: 24663016
    [Abstract] [Full Text] [Related]

  • 10. Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility.
    Kunz Coyne AJ, Stamper K, Kebriaei R, Holger DJ, El Ghali A, Morrisette T, Biswas B, Wilson M, Deschenes MV, Canfield GS, Duerkop BA, Arias CA, Rybak MJ.
    Antibiotics (Basel); 2022 Aug 30; 11(9):. PubMed ID: 36139953
    [Abstract] [Full Text] [Related]

  • 11. Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Steed ME, Vidaillac C, Rybak MJ.
    Antimicrob Agents Chemother; 2010 Dec 30; 54(12):5187-92. PubMed ID: 20921318
    [Abstract] [Full Text] [Related]

  • 12. In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates.
    Davis KP, McDermott LA, Snydman DR, Aldridge BB.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0097624. PubMed ID: 38916355
    [Abstract] [Full Text] [Related]

  • 13. In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure.
    Bhalodi AA, Hagihara M, Nicolau DP, Kuti JL.
    Antimicrob Agents Chemother; 2014 Aug 06; 58(2):672-7. PubMed ID: 24217694
    [Abstract] [Full Text] [Related]

  • 14. Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens.
    Kunz Coyne AJ, Eshaya M, Bleick C, Vader S, Biswas B, Wilson M, Deschenes MV, Alexander J, Lehman SM, Rybak MJ.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0042724. PubMed ID: 39082827
    [Abstract] [Full Text] [Related]

  • 15. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR, Yim J, Raut A, Rybak MJ.
    Antimicrob Agents Chemother; 2016 Apr 03; 60(4):2352-8. PubMed ID: 26833159
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Biofilm Model.
    Jahanbakhsh S, Singh NB, Yim J, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2018 Aug 03; 62(8):. PubMed ID: 29784849
    [Abstract] [Full Text] [Related]

  • 17. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model.
    Jahanbakhsh S, Singh NB, Yim J, Kebriaei R, Smith JR, Lev K, Tran TT, Rose WE, Arias CA, Rybak MJ.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32094136
    [Abstract] [Full Text] [Related]

  • 18. A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant Staphylococcus aureus.
    Barber KE, Werth BJ, McRoberts JP, Rybak MJ.
    Antimicrob Agents Chemother; 2014 May 21; 58(5):2989-92. PubMed ID: 24614378
    [Abstract] [Full Text] [Related]

  • 19. Pre-clinical Impact of the Synergistic Mechanism of Daptomycin and Ceftaroline on Patients with Methicillin-resistant Staphylococcus aureus Bacteremia Infections.
    Eliazar J, Johnson T, Chbib C.
    Curr Rev Clin Exp Pharmacol; 2021 May 21; 16(4):296-299. PubMed ID: 33423652
    [Abstract] [Full Text] [Related]

  • 20. A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).
    Shafiq I, Bulman ZP, Spitznogle SL, Osorio JE, Reilly IS, Lesse AJ, Parameswaran GI, Mergenhagen KA, Tsuji BT.
    Infect Dis (Lond); 2017 May 21; 49(5):410-416. PubMed ID: 28116950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.